Canada markets open in 4 hours 1 minute

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
160.55-5.70 (-3.43%)
At close: 4:00PM EDT
132.64 -27.91 (-17.38%)
Pre-Market: 05:29AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close166.25
Open167.42
Bid0.00 x 800
Ask0.00 x 3200
Day's Range160.25 - 173.37
52 Week Range76.59 - 331.68
Volume2,962,992
Avg. Volume5,024,323
Market Cap11.958B
Beta (5Y Monthly)1.59
PE Ratio (TTM)N/A
EPS (TTM)-13.84
Earnings DateNov. 08, 2021 - Nov. 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est264.20
  • Editor's Pick
    Yahoo Finance Video

    How innovations in Covid-19 testing will play a part in this winter season

    Thierry Bernard, QIAGEN CEO, joins Yahoo Finance to discuss the future of Covid-19 testing, interest and supply of at-home covid testing, and the diagnostic industry amid the pandemic.

  • Motley Fool

    5 of the Fastest-Growing Stocks On the Planet

    For instance, AMC Entertainment (NYSE: AMC) reported 2,252% revenue growth in its most recent quarter. Last year at this time, the COVID-19 lockdown was crushing a lot of stocks, with revenues dropping to near-zero for many companies. While some of these stocks are "turn around" stories, all of the stocks in this article have strong financials and are way safer than AMC.

  • Motley Fool

    Why Shares of Moderna, Novavax, and Ocugen Are Falling Today

    Shares of Moderna (NASDAQ: MRNA) are off by 3.4%; Novavax (NASDAQ: NVAX) is down 5.1%; and Ocugen's (NASDAQ: OCGN) stock is in the red by a jaw-dropping 13.3%, all as of 3:34 p.m. EDT Friday. The U.S. Food and Drug Administration (FDA) might delay the decision on Moderna's jab for adolescents due to safety issues, according to a report from the Wall Street Journal.